Patents by Inventor Tom Berkelman

Tom Berkelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11905335
    Abstract: Methods and kits for purifying protein-nanoparticle conjugates are provided. In some embodiments, a multimodal medium having a size exclusion mode and a capture mode is used to purify the protein-nanoparticle conjugates.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: February 20, 2024
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Jiali Liao, Tom Berkelman
  • Publication number: 20210179736
    Abstract: Methods and kits for purifying protein-nanoparticle conjugates are provided. In some embodiments, a multimodal medium having a size exclusion mode and a capture mode is used to purify the protein-nanoparticle conjugates.
    Type: Application
    Filed: February 2, 2021
    Publication date: June 17, 2021
    Inventors: Jiali LIAO, Tom BERKELMAN
  • Patent number: 10934366
    Abstract: Methods and kits for purifying protein-nanoparticle conjugates are provided. In some embodiments, a multimodal medium having a size exclusion mode and a capture mode is used to purify the protein-nanoparticle conjugates.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 2, 2021
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Jiali Liao, Tom Berkelman
  • Patent number: 10048270
    Abstract: Methods and compositions are provided for validating immunological detection reagents for use in detecting contaminating host cell components in a biological preparation.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: August 14, 2018
    Assignee: Bio-Rad Laboratories, Inc.
    Inventor: Tom Berkelman
  • Publication number: 20180086850
    Abstract: Methods and kits for purifying protein-nanoparticle conjugates are provided. In some embodiments, a multimodal medium having a size exclusion mode and a capture mode is used to purify the protein-nanoparticle conjugates.
    Type: Application
    Filed: September 25, 2017
    Publication date: March 29, 2018
    Inventors: Jiali LIAO, Tom BERKELMAN
  • Publication number: 20160291033
    Abstract: Methods and compositions are provided for validating immunological detection reagents for use in detecting contaminating host cell components in a biological preparation.
    Type: Application
    Filed: November 12, 2014
    Publication date: October 6, 2016
    Inventor: Tom Berkelman
  • Publication number: 20150377869
    Abstract: Methods of purifying antibody-nanoparticle conjugates with size exclusion chromatography are provided.
    Type: Application
    Filed: June 24, 2015
    Publication date: December 31, 2015
    Inventors: Tom Berkelman, Jiali Liao
  • Patent number: 8664396
    Abstract: A method of staining a poly(amino acid) by contacting a poly(amino acid) with an overall neutral or overall cationic complex of at least one of transition metal ion, and a plurality of donor ligands each of which is fully coordinated to the transition metal ion and is either a nitrogen donor ligand or a cyclometalated donor ligand, such that at least one of the donor ligands is a cyclometalated donor ligand. Nitrogen donor ligands will contain heteroaryl ring systems having from 10 to 40 ring atoms, wherein each nitrogen donor ligand is substituted with from 0 to 4 R1 groups. Cyclometalated donor ligands will likewise contain heteroaryl ring systems having from 10 to 40 ring atoms, such that at least one ring atom is N, wherein each cyclometalated donor ligand is substituted with from 0 to 4 R1 groups. R1, R2, R3 and R4 groups are defined herein.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: March 4, 2014
    Assignee: Bio-Rad Laboratories, Inc.
    Inventor: Tom Berkelman
  • Publication number: 20090131640
    Abstract: A method of staining a poly(amino acid) by contacting a poly(amino acid) with a complex of at least one of transition metal ion, and a plurality of donor ligands each of which is fully coordinated to the transition metal ion and is either a nitrogen donor ligand or a cyclometalated donor ligand, such that at least one of the donor ligands is a cyclometalated donor ligand. Donor ligands in a single complex can be the same or different. Nitrogen donor ligands will contain heteroaryl ring systems having from 10 to 40 ring atoms, where from 2 to 8 ring atoms are N, O, S, or combinations thereof, such that at least two ring atoms are N, wherein each nitrogen donor ligand is substituted with from 0 to 4 R1 groups. Cyclometalated donor ligands will likewise contain heteroaryl ring systems having from 10 to 40 ring atoms, where from 1 to 4 ring atoms are N, O, S or combinations thereof, such that at least one ring atom is N, wherein each Cyclometalated donor ligand is substituted with from 0 to 4 R1 groups.
    Type: Application
    Filed: November 20, 2008
    Publication date: May 21, 2009
    Applicant: Bio-Rad Laboratories, Inc.
    Inventor: Tom Berkelman